Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Broussonetia papyrifera extract helps hair growth by regulating specific proteins.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Natural skincare products may help reduce sun damage and support the skin's daily cycle.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Marine-derived saccharides may help reduce aging effects on skin and hair by promoting cell growth and collagen production.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib may effectively treat folliculitis decalvans.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.